UnitedHealth Group Makes $3 Billion Investment in AI Technology

UnitedHealth Group is making a $3 billion investment in artificial intelligence technology, deploying AI tools across cybersecurity, claims review, fraud detection, and provider technology, with more than 80% of its 22,000 software engineers worldwide now using AI to write code. Patient advocate Grace Cordovano criticizes this rapid AI adoption as creating a war of algorithms with patients' lives in the middle. Meanwhile, the University of Southern Denmark has put on hold a proposed hepatitis B vaccine trial in Guinea-Bissau after the WHO deemed it unethical, despite the vaccine's 40-year safety record. The trial would have randomized babies to receive their first hepatitis B dose at birth versus the current standard of two months, ahead of Guinea-Bissau's planned 2028 adoption of birth-dose vaccination.

UnitedHealth Group's $3 Billion AI Investment and Healthcare Transformation

• ▪UnitedHealth Group employs 22,000 software engineers worldwide
• ▪UnitedHealth Group has hundreds of job openings for AI positions related to cybersecurity, claims review and editing, fraud detection, and provider digital technology
• ▪More than 80% of UnitedHealth Group's software engineers use AI to write code or build new agents

Ethical Controversy Over Guinea-Bissau Hepatitis B Vaccine Trial

• ▪The Danish National Committee on Health Research Ethics stated it does not have jurisdiction to conduct an ethical assessment of the proposed Guinea-Bissau hepatitis B vaccine trial
• ▪The hepatitis B vaccine has been used in infants for more than 40 years
• ▪Guinea-Bissau plans to adopt a birth-dose hepatitis B vaccine strategy in 2028
• ▪The University of Southern Denmark put the proposed Guinea-Bissau hepatitis B vaccine trial on hold while investigating critiques of its ethics

RFK Jr.'s Contradictory Stance on Peptides vs. Vaccines

• ▪Health Secretary Robert F. Kennedy Jr. indicated that the FDA would make peptides more accessible
• ▪Health Secretary Robert F. Kennedy Jr. stated he has used peptides himself

Raw Farm's E. coli Outbreak and Contested Product Recall

• ▪Raw Farm's cheddar cheese products are the focus of the recall related to an E. coli outbreak
• ▪Raw Farm described its recall as a voluntary recall being performed under protest
• ▪The FDA asked Raw Farm for weeks to recall its unpasteurized cheese products while investigating an E. coli outbreak
• ▪Raw Farm refused to recall its products until Thursday of the week before April 6, 2026
• ▪Raw Farm posted a company announcement on Friday stating the recall was being performed under protest

Perspective of Grace Cordovano (Patient advocates)

• ▪Grace Cordovano characterizes AI adoption in healthcare as a war of algorithms with patients' lives caught in the middle

Perspective of UnitedHealth Group

• ▪UnitedHealth Group is investing $3 billion in artificial intelligence technology across its operations

Perspective of University of Southern Denmark

• ▪The University of Southern Denmark sought independent ethical assessment of its Guinea-Bissau hepatitis B vaccine trial from the European Network of Research Ethics Committees

Perspective of World Health Organization

• ▪The World Health Organization declared the University of Southern Denmark's proposed Guinea-Bissau hepatitis B vaccine trial to be unethical